Volpara Health Technologies (ASX:VHT) ROE % Adjusted to Book Value : -4.28% (As of Sep. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Volpara Health Technologies ROE % Adjusted to Book Value?

Volpara Health Technologies's ROE % for the quarter that ended in Sep. 2023 was -17.72%. Volpara Health Technologies's PB Ratio for the quarter that ended in Sep. 2023 was 4.14. Volpara Health Technologies's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2023 was -4.28%.

Volpara Health Technologies ROE % Adjusted to Book Value Historical Data

The historical data trend for Volpara Health Technologies's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Volpara Health Technologies ROE % Adjusted to Book Value Chart

Volpara Health Technologies Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-6.82

-13.42

-5.58

-6.16

-4.49

Volpara Health Technologies Semi-Annual Data
	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial										-5.24	-6.01	-6.29	-4.66	-4.28

Competitive Comparison of Volpara Health Technologies's ROE % Adjusted to Book Value

For the Health Information Services subindustry, Volpara Health Technologies's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Volpara Health Technologies's ROE % Adjusted to Book Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Volpara Health Technologies's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Volpara Health Technologies's ROE % Adjusted to Book Value falls into.

Volpara Health Technologies ROE % Adjusted to Book Value Calculation

Volpara Health Technologies's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-18.03%	/	4.02
	=	-4.49%

Volpara Health Technologies's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-17.72%	/	4.14
	=	-4.28%

Volpara Health Technologies ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Volpara Health Technologies's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Volpara Health Technologies (ASX:VHT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Volpara Health Technologies Ltd (ASX:VHT) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

VPAHF:USA

Address

40 Mercer Street, Level 14–15, Wellington Central, Wellington, NZL, 6011

Website

https://www.volparahealth.com

Volpara Health Technologies Ltd is a New Zealand-based research, development, and manufacturing company. The business of the company operates through three product categories that include Capital Sales, Software Maintenance Agreements, and Software as a Service. It offers a breast imaging analytics platform that delivers real-time quality assurance and performance monitoring. It operates through the sale of a single suite of medical device software products.